Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Revenue

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATH BIOGENES (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Net Sales ₹365 Cr₹333 Cr₹301 Cr₹278 Cr₹138 Cr

What is the latest Revenue of NATH BIOGENES (INDIA) ?

The latest Revenue ratio of NATH BIOGENES (INDIA) is ₹365 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹365 Cr
Mar2024₹333 Cr
Mar2023₹301 Cr
Mar2022₹278 Cr
Mar2013₹138 Cr

How is Revenue of NATH BIOGENES (INDIA) Trending?

Years Revenue % Change
Mar2025 ₹365 Cr
9.71
Mar2024 ₹333 Cr
10.37
Mar2023 ₹301 Cr
8.26
Mar2022 ₹278 Cr
102.15
Mar2013 ₹138 Cr -

Compare Revenue of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹276.4 Cr 2.5% -6.4% -16.6% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹11,696.2 Cr -1.5% -11.3% -18.3% Stock Analytics
KAVERI SEED COMPANY ₹4,562.7 Cr 6.1% -10% 4.3% Stock Analytics
VENKYS (INDIA) ₹2,130.2 Cr 1.4% -0.3% -5% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹930.8 Cr -3.5% -15.7% -41.2% Stock Analytics
INDO US BIOTECH ₹240.7 Cr -3.3% -1.8% -43.6% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

2.5%

-6.4%

-16.6%

SENSEX

-1%

-4.7%

6%


You may also like the below Video Courses